Encorafenib Plus Cetuximab in a Neoadjuvant Setting in Patients With BRAF Mutation Localised Colon or Upper Rectum Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
DOR/ISL in HIV-1 Antiretroviral Treatment-naïve Participants (MK-8591A-053)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
AIO-BNHO Comprehensive Clinico-genomics Database Network - AIO-BNHO CONNECT
- Status
- RECRUITING
- Phase
- N/A
MK-8510 Monotherapy for the Treatment of Anti-retroviral naïve Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8510-002)
- Status
- WITHDRAWN
- Phase
- PHASE1
Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008)
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Study of Nemtabrutinib in Japanese Participants With Hematological Malignancies (MK-1026-002)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Oral IRAK-4 Inhibitor CA-4948 in Combination With Pembrolizumab and Stereotactic Radiosurgery in Patients With Melanoma Brain Metastases
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug Discontinuation
- Status
- COMPLETED
- Phase
- N/A
A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)
- Status
- COMPLETED
- Phase
- PHASE3
Investigating HPV Vaccination Uptake in Adults Aged 18-35 Seeking Care at a Health Clinic in Rural Mississippi
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
A Study of MK-2060 in Participants With Chronic and/or End-Stage Kidney Disease (MK-2060-011)
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study on PhArmacokinetics of First liNe Antiretrovirals in Healthy Breastfeeding Volunteers
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Immunogenicity of V116 in Vaccine-naïve Japanese Older Adults (V116-009, STRIDE-9)
- Status
- COMPLETED
- Phase
- PHASE3
Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-052)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3